Rizafilm patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US9301948 INTELGENX CORP Instantly wettable oral film dosage form without surfactant or polyalcohol
Jul, 2034

(10 years from now)

Rizafilm is owned by Intelgenx Corp.

Rizafilm contains Rizatriptan Benzoate.

Rizafilm has a total of 1 drug patent out of which 0 drug patents have expired.

Rizafilm was authorised for market use on 14 April, 2023.

Rizafilm is available in film;oral dosage forms.

The generics of Rizafilm are possible to be released after 30 July, 2034.

Drugs and Companies using RIZATRIPTAN BENZOATE ingredient

Market Authorisation Date: 14 April, 2023

Treatment: NA


More Information on Dosage

RIZAFILM family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic